Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomaras

Showing results (181-190 of 525) with videos related to

Pageof 53
Sort By:
Plos One|September 21, 2011
Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trialBeryl A Koblin, Martin Casapia, Cecilia Morgan, et al.
Journal of Virology|December 15, 2017
A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus MacaquesAndrew T Jones, Venkateswarlu Chamcha, Sannula Kesavardhana, et al.
The Journal of Infectious Diseases|September 9, 2015
λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein AntibodiesMohammad M Sajadi, Maham Farshidpour, Eric P Brown, et al.
Journal of Virology|March 25, 2016
Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman PrimatesRoger Le Grand, Nathalie Dereuddre-Bosquet, Stefania Dispinseri, et al.
Frontiers in Immunology|December 13, 2019
Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector CellsLeigh Fisher, Melissa Zinter, Sherry Stanfield-Oakley, et al.
Infection and Immunity|January 22, 2015
Role of the carboxy terminus of SecA in iron acquisition, protein translocation, and virulence of the bacterial pathogen Acinetobacter baumanniiSteven E Fiester, Chika C Nwugo, William F Penwell, et al.
Journal of Virology|February 6, 2015
CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infectionSuefen Kwa, Shanmugalakshmi Sadagopal, Xiaoying Shen, et al.
Journal of Virology|October 13, 2017
HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same VaccineErin P McGuire, Youyi Fong, Christopher Toote, et al.
Nature Communications|February 20, 2019
HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challengeAndrew T Jones, Xiaoying Shen, Korey L Walter, et al.
Vaccine|January 15, 2020
Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01<sub>B</sub> vaccinationOlivier Van Der Meeren, Erik Jongert, Kelly E Seaton, et al.
Pageof 53

Showing results (181-190 of 525) with videos related to

Sort By:
Pageof 53
Plos One|September 21, 2011
Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trialBeryl A Koblin, Martin Casapia, Cecilia Morgan, et al.
Journal of Virology|December 15, 2017
A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus MacaquesAndrew T Jones, Venkateswarlu Chamcha, Sannula Kesavardhana, et al.
The Journal of Infectious Diseases|September 9, 2015
λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein AntibodiesMohammad M Sajadi, Maham Farshidpour, Eric P Brown, et al.
Journal of Virology|March 25, 2016
Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman PrimatesRoger Le Grand, Nathalie Dereuddre-Bosquet, Stefania Dispinseri, et al.
Frontiers in Immunology|December 13, 2019
Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector CellsLeigh Fisher, Melissa Zinter, Sherry Stanfield-Oakley, et al.
Infection and Immunity|January 22, 2015
Role of the carboxy terminus of SecA in iron acquisition, protein translocation, and virulence of the bacterial pathogen Acinetobacter baumanniiSteven E Fiester, Chika C Nwugo, William F Penwell, et al.
Journal of Virology|February 6, 2015
CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infectionSuefen Kwa, Shanmugalakshmi Sadagopal, Xiaoying Shen, et al.
Journal of Virology|October 13, 2017
HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same VaccineErin P McGuire, Youyi Fong, Christopher Toote, et al.
Nature Communications|February 20, 2019
HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challengeAndrew T Jones, Xiaoying Shen, Korey L Walter, et al.
Vaccine|January 15, 2020
Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01<sub>B</sub> vaccinationOlivier Van Der Meeren, Erik Jongert, Kelly E Seaton, et al.
Pageof 53